Altered expression of syndecan-1 in prostate cancer. - Wikidata - awgldk - TriplyDB

Altered expression of syndecan-1 in prostate cancer.

Altered expression of syndecan-1 in prostate cancer.

http://www.wikidata.org/entity/Q42830140

about

Polyunsaturated fatty acid metabolism in prostate cancer Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention 15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.Molecular functions of syndecan-1 in disease.Proteoglycans in prostate cancer.Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids.Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer.

P2860

Q24629893-CD432D6A-E80D-473C-AD21-919FD091E6AF Q26796247-EF595F1D-D902-47FD-B9C2-422ECCF6D518 Q26830150-3CD87177-3E44-4386-B2D9-D0E8807E8B59 Q28277101-9D86F71B-2FE9-4717-8FD7-AE07611AF43B Q34177237-9BC9EA40-1253-4184-BA70-010BC83C7720 Q35010409-D894D8AD-3C2B-4A8E-A119-2F43E69F3DF3 Q35082892-D74E0236-FCF9-47F2-97E7-95E5DF981AFC Q37950202-591D9DF0-3A21-4E34-B107-5D8D09E7F520 Q37986399-07E343EC-820D-45A6-8AE0-F8ED96988815 Q39034367-5B47F0FF-6FDE-4C37-A1D9-977D8EDD14F1 Q39599906-A2DD2681-87E7-40CD-B111-3634E437422C Q42141004-6E2B3E34-6776-48B9-878A-D8627B9A0716

P2860

Altered expression of syndecan-1 in prostate cancer.

http://www.wikidata.org/entity/Q42830140

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Altered expression of syndecan-1 in prostate cancer.

@en

Altered expression of syndecan-1 in prostate cancer.

@nl

type

label

Altered expression of syndecan-1 in prostate cancer.

@en

Altered expression of syndecan-1 in prostate cancer.

@nl

prefLabel

Altered expression of syndecan-1 in prostate cancer.

@en

Altered expression of syndecan-1 in prostate cancer.

@nl

P1433

Q42830140-E71BCE20-6BB6-4073-A35E-7DCD85EFB06B

P1476

Q42830140-E70E823F-ED38-405E-AF74-4EB51F404C98

P2093

Q42830140-1D7C0B7C-251E-45DA-A634-3B3EC23126F8

Q42830140-2347101E-ED55-4A19-8F5E-A3FA25B49365

Q42830140-6C52A555-F81F-41F3-B169-97DD6FB1311F

Q42830140-B7386FDB-980C-4961-BDC6-69612A1D7AFB

Q42830140-BDD51B99-5CD0-4AE8-BFAC-48D7FC550AC4

Q42830140-D5B69EE8-EACA-4654-8CE3-3F19D0744FF0

Q42830140-F823BAAC-413B-49CA-BC46-772DC21D9948

P2860

Q42830140-18B551F6-DE0B-4D61-96F9-BFBCD608F7C8

Q42830140-2B9CFCF2-C615-4073-A8FF-1F3F05EC4E66

Q42830140-3A0C4444-B5A9-452C-8F82-499002F455BF

Q42830140-3B3767D6-638B-4D5C-8DD8-995412FB66ED

Q42830140-5EAAE243-54B6-4CF6-9B5C-13CC077F82D5

Q42830140-6EF1F9FB-93EC-4F2C-A6FF-202CBB31EB55

Q42830140-981E6795-E730-4AE8-90CD-632CB58EF9FA

Q42830140-A150BA28-E745-4AE1-B20C-68FB1224B79F

Q42830140-C827C687-2F73-4934-ABDA-EE55D070219F

Q42830140-F7FB4350-DA51-4C6D-BC6B-ADE9F96ED3A3

P304

Q42830140-811997E8-A434-4249-AFEB-05196F5CFD12

P31

Q42830140-A318941F-B044-45EB-AB1B-880665C3B879

P356

Q42830140-FB4E2DE5-6012-4B8F-B8A9-F2B808C40B38

P433

Q42830140-E6A08FB0-D658-438B-94D6-B5329023F668

P478

Q42830140-34BB720F-A45F-4784-BC04-51A313BB2486

P577

Q42830140-E61561BB-CD5C-49BE-BC9B-FBA9A28CDEF7

P698

Q42830140-3DB761C4-F003-4798-AE32-696BFA623A4C

P356

J.1600-0463.2004.APM1120202.X

P1433

Acta Pathologica et Microbiologica Scandinavica

P1476

Altered expression of syndecan-1 in prostate cancer.

@en

P2093

Iina Kujala

http://www.w3.org/2001/XMLSchema#string

Johanna Kiviniemi

http://www.w3.org/2001/XMLSchema#string

Kalle Alanen

http://www.w3.org/2001/XMLSchema#string

Marja-Terttu Matikainen

http://www.w3.org/2001/XMLSchema#string

Markku Jalkanen

http://www.w3.org/2001/XMLSchema#string

Markku Kallajoki

http://www.w3.org/2001/XMLSchema#string

Markku Salmivirta

http://www.w3.org/2001/XMLSchema#string

P2860

Syndecan-1 expression has prognostic significance in head and neck carcinoma

Functions of cell surface heparan sulfate proteoglycans

Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.

Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia

Overexpression and regulation of expression of scatter factor/hepatocyte growth factor in prostatic carcinoma.

Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells.

Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha.

Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.

Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study.

Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue.

P304

89-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0463.2004.APM1120202.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15056224

http://www.w3.org/2001/XMLSchema#string